BNB Plus Corp. reported significant financial changes in its latest quarterly filing for the period ending December 31, 2025. The company generated total revenues of $565,394, a decrease of 35% from $870,291 in the same period last year. This decline was primarily driven by a 97% drop in service revenues, which fell to $10,301 from $374,444, attributed to the cessation of certain services in its DNA Tagging and Security Products segment. Conversely, product revenues increased by 12% to $555,093, bolstered by higher sales to a large-scale DNA manufacturing customer.
The company's operating expenses surged to $19,023,638, a 429% increase from $3,584,287 in the prior year, largely due to a one-time consulting expense of approximately $9.4 million related to its Digital Asset Treasury strategy. This included the issuance of warrants to consultants valued at $8.8 million. As a result, BNB Plus Corp. reported a net loss of $18,606,182, compared to a loss of $2,668,713 in the previous year, marking a substantial increase in operational losses.
In terms of strategic developments, BNB Plus Corp. has undergone a significant restructuring, reducing its workforce by approximately 60% to focus on its BNB Strategy, which aims to leverage the Binance cryptocurrency for treasury management. The company also formed two new subsidiaries, Build & Build, LLC and BNBX Ltd., to manage its digital assets. The restructuring incurred pre-tax charges of about $1.2 million, with additional costs expected in the following quarter.
Operationally, BNB Plus Corp. reported a notable increase in its cash and cash equivalents, which rose to $2,450,536 from $1,667,800 at the end of the previous quarter. The company also holds digital assets valued at approximately $7.1 million and an investment in the OBNB Trust valued at $7.9 million. The total assets of the company increased significantly to $20.7 million from $4.4 million, reflecting its strategic pivot towards digital assets.
Looking ahead, BNB Plus Corp. anticipates that its current cash reserves and liquid cryptocurrency holdings will be sufficient to fund operations for the next twelve months. The company is actively implementing its BNB Strategy, which it believes will generate potential yield through various DeFi opportunities. However, the company acknowledges the inherent risks associated with cryptocurrency volatility and market conditions, which could impact its financial performance moving forward.
About APPLIED DNA SCIENCES INC
Applied DNA Sciences, Inc. is a biotechnology company specializing in the production and detection of DNA and RNA. Its key offerings include Therapeutic DNA Production Services, molecular diagnostics, and DNA tagging for supply chain security. With a focus on expanding its mRNA therapeutic capabilities, the company targets pharmaceutical developers and healthcare providers. Recent initiatives include launching a new IVT platform and expanding pharmacogenomics testing services, addressing significant market opportunities in biotechnology.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.